Notice of Effectiveness

Lexaria Bioscience Corp. Filed 2024-12-05 Acc 9999999995-24-003680

Documents 1

2024-12-17 EFFECT Notice of Effectiveness
2024-12-05 EFFECT Notice of Effectiveness
2024-12-05 424B3 Prospectus
2024-12-03 CORRESP Correspondence Between Filers and SEC Staff
2024-12-03 4 Chief Executive Officer bought 50,000 shares at an average $2.37 ($118,392)
2024-12-02 UPLOAD SEC-generated Letter
2024-06-11 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…